Dostiheal 0.25 Tablet

Dostiheal 0.25 Tablet is used for the treatment of a high level of prolactin. It is also helpful in stopping breast milk production in cases of stillbirth, abortion, or miscarriage.

Dostiheal 0.25 Tablet can be taken with or without food, but take it at the same time to get the most benefit. It should be taken as your doctor’s advice. The dose and how often you take it depend on what you take it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include nausea, headache, fatigue, depression, dizziness, and low blood pressure. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Dizziness may occur after using Dostiheal 0.25 Tablet; avoid driving or rising suddenly from a sitting or lying position.

Before taking this medicine, tell your doctor if you have ever had high blood pressure after birth or had heart disease. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Your doctor should also know about all other medicines you are taking, as many of these may make this medicine less effective or change how it works. Your doctor may check your blood pressure regularly while you are taking this medicine.

Treatment of High levels of prolactin

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dostiheal 0.25 Tablet may be taken with or without food, but it is better to take it at a fixed time.

Dostiheal 0.25 Tablet is a dopamine agonist that works by decreasing the release of prolactin, a hormone that stimulates breast milk production. This stops the production of breast milk in case of stillbirth, abortion, or miscarriage.

Q: What if you forget to take Dostiheal Tablet?
A: If you miss a dose of Dostiheal 0.25 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Dostiheal 0.25 Tablet is used to treat conditions such as infertility or abnormal production of breast milk (galactorrhea) caused due to excess production of a natural hormone called prolactin.

To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.

Consider taking it with or after food if you experience side effects such as nausea or indigestion.

Be cautious while driving or doing anything that requires concentration, as Dostiheal 0.25 Tablet can cause dizziness and sleepiness.

Regular monitoring of blood pressure may be advised during treatment with Dostiheal 0.25 Tablet.

Q. What is Dostiheal 0.25 Tablet and what is it used for?

Dostiheal 0.25 Tablet contains cabergoline, which belongs to a group of medicines that reduce the level of prolactin. It is used to treat medical problems such as galactorrhea due to abnormally high levels of prolactin. It is also used to stop breast milk production (lactation) in case of stillbirth, abortion, or miscarriage.

Q. How and in what dose should I take Dostiheal 0.25 Tablet?

Take this medicine as per the advice of your doctor. The advised dose and duration depend on your medical condition. It is recommended to take this medicine with food or after food to reduce the chances of nausea or vomiting.

Q. What are the possible side effects of using Dostiheal 0.25 Tablet?

During the first few days of treatment, this medicine may decrease your blood pressure, which could make you feel dizzy. So, it is recommended that you change your position slowly when trying to sit, stand, or lie down during the initial days of the treatment. Your doctor may suggest you monitor your blood pressure regularly during these days. The other common side effects are drowsiness, nausea, headache, dizziness, and fatigue. If any of these side effects bother you, consult your doctor.

In Treatment of High levels of prolactin

Prolactin is a hormone that helps in the growth and development of breasts and also causes milk secretion in females. Dostiheal 0.25 Tablet helps stop breast milk secretion in females who have had a stillbirth, miscarriage, or abortion. It acts on a chemical in the brain, dopamine, that is responsible for these high levels of prolactin and stops milk secretion.

Paresthesia (tingling or pricking sensation)

Weakness

Postural hypotension (low blood pressure)

Depression

Pain during periods

Nausea

Constipation

Abdominal pain

Vomiting

Headache

Dizziness

Vertigo

Fatigue

Sleepiness

Nervousness

Breast pain

Acne

Itching

Alcohol:CAUTION

Caution is advised when consuming alcohol with Dostiheal 0.25 Tablet. Please consult your doctor.

Pregnancy:CONSULT YOUR DOCTOR

Dostiheal 0.25 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding:CONSULT YOUR DOCTOR

Dostiheal 0.25 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Dostiheal 0.25 Tablet is usually not used during breastfeeding because it suppresses lactation.

Driving:UNSAFE

Dostiheal 0.25 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney:CONSULT YOUR DOCTOR

There is limited information available on the use of Dostiheal 0.25 Tablet in patients with kidney disease. Please consult your doctor.

Liver:CAUTION

Dostiheal 0.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Dostiheal 0.25 Tablet may be needed. Please consult your doctor.

Parker KL, Schimmer BP. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1114-15.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 176-709.
Cabergoline [EMC Label]. Sandwich, Kent: Pfizer Limited; 1996 [revised May 2018].[Accessed 22 Jan. 2019] (online) Available from: View
Cabergoline [Prescribing Information]. New York, NY: Pfizer; 2014. [Accessed 03 Apr. 2019] (online) Available from: View
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 03 Apr. 2019] (online) Available from: View
Cabergoline [Prescribing Information]. Libertyville, IL: A-S Medication Solutions; 2023. [Accessed 12 Jun 2023] (online) Available from: View